News
News
- J&J posts Q2 EPS of $1.8, dropping 23.4% YoY
07/19/2022 / 12:26 - TeleTrader - FDA limits J&J vaccine use due to blood clot risks
05/06/2022 / 02:58 - TeleTrader - J&J's Q1 sales up 5% YoY to $23.4B
04/19/2022 / 12:27 - TeleTrader - CDC confirms additional boosters for over-50s
03/29/2022 / 22:41 - TeleTrader - Johnson: Putin must know he would pay high price for invasion
02/19/2022 / 11:37 - TeleTrader - Report: J&J quietly paused COVID vaccine production
02/08/2022 / 17:01 - TeleTrader - J&J Q4 EPS soars 172.3% to $1.77
01/25/2022 / 12:31 - TeleTrader - J&J booster 85% effective against hospitalization in S. Africa
12/30/2021 / 13:24 - TeleTrader - Switzerland approves J&J booster
12/27/2021 / 15:59 - TeleTrader - S. Africa to start rollout of vaccine boosters today
12/24/2021 / 09:45 - TeleTrader
Real-time